Trial · NCT01428453
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 30
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline (Day 0) in Cerebral Spinal Fluid (CSF) Amyloid Beta Peptide (Abeta) 42 and Abeta40 at Week 24 | Placebo Once Daily | Abeta42 | -6.3 | Standard Error 18.10 | Nanograms per Liter |
| Change From Baseline (Day 0) in Cerebral Spinal Fluid (CSF) Amyloid Beta Peptide (Abeta) 42 and Abeta40 at Week 24 | Rilapladib 250 mg Once Daily | Abeta42 | 33.6 | Standard Error 19.02 | Nanograms per Liter |
| Change From Baseline (Day 0) in Cerebral Spinal Fluid (CSF) Amyloid Beta Peptide (Abeta) 42 and Abeta40 at Week 24 | Placebo Once Daily | Abeta40 | -77.4 | Standard Error 181.33 | Nanograms per Liter |
| Change From Baseline (Day 0) in Cerebral Spinal Fluid (CSF) Amyloid Beta Peptide (Abeta) 42 and Abeta40 at Week 24 | Rilapladib 250 mg Once Daily | Abeta40 | -327.7 | Standard Error 190.56 | Nanograms per Liter |
| Change From Baseline (Day 0) in CSF Abeta42/ Abeta40 Ratio at Week 24 | Placebo Once Daily | 0.002 | Standard Error 0.0068 | Ratio | |
| Change From Baseline (Day 0) in CSF Abeta42/ Abeta40 Ratio at Week 24 | Rilapladib 250 mg Once Daily | 0.018 | Standard Error 0.0071 | Ratio | |
| Change From Baseline (Day 0) in CSF Tau and Phosphorylated Tau (P-tau) Measures at Week 24 | Placebo Once Daily | CSF tau | 38.2 | Standard Error 29.98 | Nanograms per Liter |
| Change From Baseline (Day 0) in CSF Tau and Phosphorylated Tau (P-tau) Measures at Week 24 | Rilapladib 250 mg Once Daily | CSF tau | -18.8 | Standard Error 31.90 | Nanograms per Liter |
| Change From Baseline (Day 0) in CSF Tau and Phosphorylated Tau (P-tau) Measures at Week 24 | Placebo Once Daily | P-tau | 1.3 | Standard Error 1.67 | Nanograms per Liter |
| Change From Baseline (Day 0) in CSF Tau and Phosphorylated Tau (P-tau) Measures at Week 24 | Rilapladib 250 mg Once Daily | P-tau | -1.7 | Standard Error 1.76 | Nanograms per Liter |
| Change From Baseline (Day 0) in the Computerized Test Battery for Cognition (CogState) Battery Working Memory/Executive Function (WM/EF) Composite Score at Week 24 | Placebo Once Daily | -0.150 | Standard Error 0.0501 | Scores on a scale | |
| Change From Baseline (Day 0) in the Computerized Test Battery for Cognition (CogState) Battery Working Memory/Executive Function (WM/EF) Composite Score at Week 24 | Rilapladib 250 mg Once Daily | 0.016 | Standard Error 0.0538 | Scores on a scale | |
| Change From Baseline (Day 0) in CSF Albumin Quotients at Week 24 | Placebo Once Daily | 0.11 | Standard Error 0.172 | Nanograms per Liter | |
| Change From Baseline (Day 0) in CSF Albumin Quotients at Week 24 | Rilapladib 250 mg Once Daily | -0.13 | Standard Error 0.184 | Nanograms per Liter | |
| Change From Baseline (Day 0) in Plasma Levels of Abeta42 and Abeta40 at Week 24 | Placebo Once Daily | Abeta42 | 1.5 | Standard Error 0.90 | Nanograms per Liter |
| Change From Baseline (Day 0) in Plasma Levels of Abeta42 and Abeta40 at Week 24 | Rilapladib 250 mg Once Daily | Abeta42 | 0.2 | Standard Error 0.94 | Nanograms per Liter |
| Change From Baseline (Day 0) in Plasma Levels of Abeta42 and Abeta40 at Week 24 | Placebo Once Daily | Abeta40 | 8.8 | Standard Error 3.91 | Nanograms per Liter |
| Change From Baseline (Day 0) in Plasma Levels of Abeta42 and Abeta40 at Week 24 | Rilapladib 250 mg Once Daily | Abeta40 | 9.7 | Standard Error 4.06 | Nanograms per Liter |
| Change From Baseline (Day 0) in Plasma Levels of Abeta42/Abeta40 Ratio at Week 24 | Placebo Once Daily | -0.010 | Standard Error 0.0045 | Ratio | |
| Change From Baseline (Day 0) in Plasma Levels of Abeta42/Abeta40 Ratio at Week 24 | Rilapladib 250 mg Once Daily | -0.012 | Standard Error 0.0047 | Ratio |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01428453/results